Breaking News Instant updates and real-time market news.

ACIA

Acacia Communications

$102.00

2.5 (2.51%)

, CRBP

Corbus Pharmaceuticals

$7.02

0.15 (2.18%)

17:26
10/04/16
10/04
17:26
10/04/16
17:26

On The Fly: After Hours Movers

UP AFTER EARNINGS: Acacia Communications (ACIA), up 5.4%. ALSO HIGHER: Corbus Pharmaceuticals (CRBP), up 6.1% after the stock was initiated with a Buy rating at Cantor... TeamHealth (TMH), up 1.2% after the Wall Street Journal reported that the company is considering a possible sale to Blackstone (BX) or Bain Capital. DOWN AFTER EARNINGS: Micron (MU), down 2.3%. ALSO LOWER: Universal Logistics (ULH), down 11% after reporting preliminary Q3 results... Cascade (CASC), down 7.7% after announcing a plan for a reverse stock split.

ACIA

Acacia Communications

$102.00

2.5 (2.51%)

CRBP

Corbus Pharmaceuticals

$7.02

0.15 (2.18%)

TMH

TeamHealth

$38.20

5.4 (16.46%)

BX

Blackstone

$25.09

-0.1 (-0.40%)

MU

Micron

$17.80

0.07 (0.39%)

ULH

Universal Logistics

$13.22

-0.08 (-0.60%)

CASC

Cascadian Therapeutics

$1.68

0.06 (3.70%)

  • 04

    Oct

  • 06

    Oct

  • 27

    Oct

  • 07

    Oct

ACIA Acacia Communications
$102.00

2.5 (2.51%)

09/09/16
DBAB
09/09/16
NO CHANGE
Target $125
DBAB
Buy
Acacia Communications price target raised to $125 from $90 at Deutsche Bank
Deutsche Bank analyst Vijay Bhagavath raised his price target for Acacia Communications to $125 from $90 after joining the company's CEO and CFO in a non-deal roadshow. The analyst sees "little risk" to Q3 estimates given solid near-term order visibility in Datacenter Optical and China Metro build outs. The consensus view of Acacia's total addressable market at $4B is conservative and does not factor in up-sell into a $1B-$2B 100G Switching and Routing market, Bhagavath tells investors in a research note. He reiterates a Buy rating on the shares. Acacia closed yesterday down $2.31 to $117.89.
09/01/16
BOFA
09/01/16
NO CHANGE
Target $130
BOFA
Buy
Acacia Communications price target raised ot $130 from $88 at BofA/Merrill
BofA/Merrill analyst Tal Llani raised Acacia Communications' price target to $130 from $88 to reflect potential share gains and TAM expansion. The analyst remains constructive on shares despite recent strength given product superiority, sales growth, and potential upside to Street estimates. Llani rates Acacia a Buy.
08/18/16
NEED
08/18/16
NO CHANGE
NEED
Nokia, Alcatel-Lucent win positive for optical component companies, says Needham
Needham analyst Alex Henderson says that Alcatel-Lucent (ALU)/Nokia (NOK) announcement of a major contract win to build over 30% share of China Mobile's (CHL) 2016-2017 new construction of optical network is also a major positive for optical component companies such as Oclaro (OCLR), NeoPhotonics (NPTN), Fabrinet (FN), Lumentum (LITE), Inphi (IPHI), and Acacia (ACIA). Henderson thinks this is likely the first of three major awards in China, which will likely result in the current sold-out conditions in the coherent optical market to stretch out well into 2017.
09/06/16
NEED
09/06/16
NO CHANGE
Target $20
NEED
Strong Buy
Needham remains a buyer of NeoPhotonics ahead of analyst day
Needham analyst Alex Henderson believes NeoPhotonics (NPTN) is "exceptionally well positioned" for strong results over the next 3-4 quarters. The analyst "aggressively recommends" investors Buy NeoPhotonics' shares before the company's analyst day on September 8. Further, Henderson thinks Acacia's (ACIA) over $4B market cap will likely drive them to be acquisitive, and notes that it may seek to reduce costs as a percent of revenues by a potential acquisition of, for example, NeoPhotonics or Oclaro (OCLR). He reiterates a Strong Buy rating and $20 price target on NeoPhotonics' shares.
CRBP Corbus Pharmaceuticals
$7.02

0.15 (2.18%)

09/19/16
AGIS
09/19/16
NO CHANGE
Target $12
AGIS
Buy
Corbus Pharmaceuticals price target raised to $12 from $7 at Aegis
Aegis analyst Robert Leboyer raised his price target for Corbus Pharmaceuticals to $12 from $7 and keeps a Buy rating on the name.
10/04/16
CANT
10/04/16
INITIATION
Target $17
CANT
Buy
Corbus Pharmaceuticals initiated with a Buy at Cantor
Cantor initiated Corbus Pharmaceuticals with a Buy and a $17 price target.
TMH TeamHealth
$38.20

5.4 (16.46%)

09/09/16
STFL
09/09/16
NO CHANGE
STFL
TeamHealth weakness creates buying opportunity, says Stifel
Stifel analyst Chad Vanacore says that the large decline in TeamHealth's stock this year has left the shares looking undervalued and has created a buying opportunity. Vanacore is upbeat on the company's new CEO, and he continues to expect the company to benefit from current trends in the healthcare sector. He trimmed his price target on the stock to $43 from $48 but keeps a Buy rating.
08/25/16
LEER
08/25/16
NO CHANGE
Target $40
LEER
Outperform
TeamHealth price target lowered to $40 from $56 at Leerink
Leerink analyst Ana Gupte lowered her price target for TeamHealth to $40 from $56 after a weak Q2 and her meetings with the company's CEO Mike Snow and CFO David Jones. The analyst sees risks to 2016 EBITDA achievability given a quarter miss and guide-down, slower turnaround of IPC legacy business, and leverage ratio that could hamper M&A. Leerink has an Outperform rating on the shares.
08/11/16
JEFF
08/11/16
UPGRADE
Target $47
JEFF
Buy
TeamHealth upgraded to Buy from Hold at Jefferies
Jefferies analyst Brian Tanquilut upgraded TeamHealth to Buy saying both the valuation and investor expectations have hit "trough levels." Any progress with operational execution should drive the stock higher, Tanquilut tells investors in a research note. He lowered his price target for the shares to $47 from $49.
09/26/16
SBSH
09/26/16
INITIATION
Target $36
SBSH
Neutral
TeamHealth initiated with a Neutral at Citi
Citi analyst Ralph Giacobbe started TeamHealth Holdings with a Neutral rating and $36 price target.
BX Blackstone
$25.09

-0.1 (-0.40%)

12/14/15
12/14/15
INITIATION

On The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Atwood Oceanics (ATW) initiated with a Hold at KLR Group... Axsome Therapies (AXSM) initiated with a Buy at Ladenburg... Blackstone (BX) initiated with an Outperform at William Blair... Build-A-Bear (BBW) initiated with a Neutral at Guggenheim... C&J Energy (CJES) initiated with a Buy at KLR Group... CARBO Ceramics (CRR) initiated with a Hold at KLR Group... Core Laboratories (CLB) initiated with a Buy at KLR Group... Diamond Offshore (DO) initiated with an Accumulate at KLR Group... Dril-Quip (DRQ) initiated with an Accumulate at KLR Group... Duke Realty (DRE) initiated with a Buy at Goldman... FMC Technologies (FTI) initiated with a Buy at KLR Group... Fairmount Santrol (FMSA) initiated with a Hold at KLR Group... Fibria Celulose (FBR) initiated with a Neutral at Goldman... Flotek (FTK) initiated with a Buy at KLR Group... Forum Energy (FET) initiated with a Buy at KLR Group... Four Corners Property Trust (FCPT) initiated with a Buy at Ladenburg... Frank's International (FI) initiated with a Buy at KLR Group... GATX Corp. (GMT) initiated with a Sell at Axiom... Greenbrier (GBX) initiated with an Outperform at Cowen... Haemonetics (HAE) initiated with a Neutral at BTIG... Halliburton (HAL) initiated with an Accumulate at KLR Group... Helmerich & Payne (HP) initiated with a Buy at KLR Group... Inuvo (INUV) initiated with a Buy at Ladenburg... Liberty Media (LMCA) initiated with an Overweight at JPMorgan... Liberty Property (LPT) initiated with a Neutral at Goldman... Luxoft (LXFT) initiated with an Outperform at William Blair... Match Group (MTCH) initiated with a Buy at Deutsche Bank... Mimecast (MIME) initiated with an Overweight at Barclays... Nabors Industries (NBR) initiated with a Buy at KLR Group... National Oilwell (NOV) initiated with a Buy at KLR Group... Newpark Resources (NR) initiated with a Buy at KLR Group... Oceaneering (OII) initiated with an Accumulate at KLR Group... Oil States (OIS) initiated with a Buy at KLR Group... Pacific Drilling (PACD) initiated with a Hold at KLR Group... Patterson-UTI (PTEN) initiated with a Buy at KLR Group... Rowan Companies (RDC) initiated with a Buy at KLR Group... Schlumberger (SLB) initiated with a Buy at KLR Group... Seadrill (SDRL) initiated with a Reduce at KLR Group... Sirius XM (SIRI) initiated with a Neutral at JPMorgan... Spirit Realty (SRC) initiated with a Buy at SunTrust... Square (SQ) initiated with a Buy at Goldman... Superior Energy (SPN) initiated with a Buy at KLR Group... Tesla (TSLA) initiated with a Market Perform at JMP Securities... Transocean (RIG) initiated with a Buy at KLR Group... Trinity Industries (TRN) initiated with an Outperform at Cowen... U.S. Silica (SLCA) initiated with a Hold at KLR Group... VMware (VMW) initiated with a Buy at Gabelli... WashingtonFirst Bankshares (WFBI) initiated with an Outperform at Raymond James... Weatherford (WFT) initiated with an Accumulate at KLR Group... Whitestone REIT (WSR) initiated with a Neutral at SunTrust... Xtera Communications (XCOM) initiated with a Buy at Needham.
03/11/16
DBAB
03/11/16
DOWNGRADE
Target $28
DBAB
Hold
Blackstone downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Brian Bedell downgraded Blackstone (BX) to Hold saying Alternative Asset Mangers will underperform over the next year amid volatile markets. The analyst lowered his price target for the shares to $28 from $30 and views Oaktree Capital (OAK) as the best positioned in the space.
03/08/16
03/08/16
NO CHANGE

Deutsche views ending of SunEdison, Vivint deal as potential positive
Deutsche Bank analyst Vishal Shah believes the termination of SunEdison's (SUNE) agreement to acquire Vivint Solar (VSLR) is a potential longer-term positive for SunEdison and TerraForm Power (TERP). The failure may also turn out to be a positive for Vivint in the long run, Shah tells investors in a research note. Investor focus will now shift from near-term liquidity and balance sheet stress for both TerraForm and SunEdison to potential legal ramifications from Vivint and Blackstone (BX), the analyst contends. He believes, however, that the legal impact may not be that significant considering the audit committee investigation and resulting lack of financing availability.
02/01/16
JMPS
02/01/16
NO CHANGE
JMPS
Blackstone outlook positive, says JMP Securities
JMP Securities says that Blackstone's underlying business trends improved in Q4, while its overall outlook is positive. The firm thinks pressure from weak markets so far this year will be transitory. It reiterates a $40 price target and Outperform rating on the shares.
MU Micron
$17.80

0.07 (0.39%)

09/29/16
NOMU
09/29/16
NO CHANGE
Target $23
NOMU
Buy
Nomura remains a Buyer of Micron, especially on weakness
Nomura analyst Romit Shah believes we are in the early part of a positive earnings revision cycle for Micron. The analyst raised his November earnings estimate to 17c, above consensus of 8c, but below "perceived" consensus of 20c-25c. Shah said DRAM's pricing outlook is the key driver as pricing and mix are improving. The analyst remains a buyer of Micron and reiterates his Buy rating and $23 price target.
10/03/16
MSCO
10/03/16
NO CHANGE
MSCO
Overweight
Morgan Stanley continues to recommend buying Micron
Morgan Stanley analyst Joseph Moore recommends to continue buying Micron given the strong pricing backdrop and strong DRAM bit growth the last 2 quarters, which should drive an earnings inflection higher. Moore sees upside to Q1 numbers and an upward revision to his FY17 $1.22 estimate as he expects DRAM pricing to remain strong, with NAND a bit more mixed, for the next several quarters. The analyst is not making a trade into tomorrow's report due to lack of transparency into guidance, but recommends buying shares into a strong November quarter and beyond. Moore rates Micron a Buy with a $20 price target on shares.
09/16/16
09/16/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Wal-Mart (WMT) coverage assumed with an Outperform from Neutral at Credit Suisse with analyst Edward Kelly saying he is encouraged by Wal-Mart's return to traffic growth against a deteriorating staples retail environment and its aggressive U.S. investments to solidify its position in an evolving industry. 2. Clorox (CLX) upgraded to Overweight from Neutral at Atlantic Equities. 3. Comerica (CMA) upgraded to Conviction Buy from Neutral at Goldman with analyst Ryan Nash saying he sees upside to Comerica's current recently announced strategic plan to improve pre-tax returns by $230M. 4. Hormel Foods (HRL) upgraded to Buy from Hold at Edward Jones. 5. Micron (MU) upgraded to Buy from Neutral at Cleveland Research with analyst Kevin Rottinghaus saying Micron's execution has improved and progress in DRAM and NAND fundamentals over the past 2-3 months is sustainable into 2017. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/16/16
CLVD
09/16/16
UPGRADE
CLVD
Buy
Micron upgraded to Buy on sustainable DRAM and NAND at Cleveland Research
As previously reported, Cleveland Research upgraded Micron to Buy from Neutral. Analyst Kevin Rottinghaus said Micron's execution has improved and progress in DRAM and NAND fundamentals over the past 2-3 months is sustainable into 2017. He sees several catalysts over the next 12 months including DRAM demand outpacing bit supply growth for CY17, improved DRAM demand outlook for computing, data center, and mobile, improving execution at 20nm, Micron appearing to be second to market with 3D SSD solutions, and NAND expected to be in tight supply through 2017. Rottinghaus expects additional material positive estimate revisions over the next 6+ months.
ULH Universal Logistics
$13.22

-0.08 (-0.60%)

05/05/16
STFL
05/05/16
UPGRADE
STFL
Buy
Universal Logistics upgraded to Buy from Hold at Stifel
CASC Cascadian Therapeutics
$1.68

0.06 (3.70%)

06/22/16
06/22/16
NO CHANGE

Cascade files to sell common stock, convertible preferred stock
Cascade announced that it intends to offer and sell shares of its common stock in an underwritten public offering. Additionally, concurrently with the common stock offering, Cascadian Therapeutics intends to sell shares of Series D convertible preferred stock having an aggregate value of up to $13.8 million directly to affiliates of BVF Partners L.P., which are existing stockholders and affiliates of a member of the board of directors of Cascadian Therapeutics. Cowen and Company, LLC is acting as the sole book-running manager, and Trout Capital LLC is acting as a co-manager in the offering of common stock. Cowen and Company, LLC and Trout Capital LLC will also act as placement agents in connection with the sale of Series D convertible preferred stock.

TODAY'S FREE FLY STORIES

QRVO

Qorvo

$66.19

-1.01 (-1.50%)

, SWKS

Skyworks

$94.70

-0.61 (-0.64%)

13:59
02/26/17
02/26
13:59
02/26/17
13:59
Periodicals
Qorvo, Skyworks look like better bets in mobile chips, Barron's says »

Qualcomm (QCOM) and…

QRVO

Qorvo

$66.19

-1.01 (-1.50%)

SWKS

Skyworks

$94.70

-0.61 (-0.64%)

QCOM

Qualcomm

$57.22

0.08 (0.14%)

INTC

Intel

$36.53

0.35 (0.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 13

    Mar

  • 19

    Mar

  • 04

    Apr

  • 05

    Apr

JCP

J.C. Penney

$6.46

-0.4 (-5.83%)

13:59
02/26/17
02/26
13:59
02/26/17
13:59
Conference/Events
J.C. Penney participates in a conference call with Aegis Capital »

Aegis Capital hosts a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAM

Boston Beer

$159.20

1.3 (0.82%)

13:52
02/26/17
02/26
13:52
02/26/17
13:52
Periodicals
Boston Beer looks expensive, Barron's says »

Despite dropping…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXTA

Axalta Coating

$29.38

-0.09 (-0.31%)

13:33
02/26/17
02/26
13:33
02/26/17
13:33
Periodicals
Axalta Coating could rise 20% or more, Barron's says »

Axalta Coating looks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPN

Global Payments

$78.97

0.76 (0.97%)

13:30
02/26/17
02/26
13:30
02/26/17
13:30
Periodicals
Global Payments could offer 15% upside, Barron's says »

Shares of Global Payments…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

RIG

Transocean

$13.75

-0.56 (-3.91%)

13:07
02/26/17
02/26
13:07
02/26/17
13:07
Periodicals
Transocean could rally 35% or more over next several years, Barron's says »

"Patient"…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TV

Grupo Televisa

$26.44

0.69 (2.68%)

12:57
02/26/17
02/26
12:57
02/26/17
12:57
Periodicals
Grupo Televisa could rise 20% or more in a year, Barron's says »

Grupo Televisa's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HOG

Harley-Davidson

$56.56

-1.12 (-1.94%)

12:46
02/26/17
02/26
12:46
02/26/17
12:46
Periodicals
Harley-Davidson looks overvalued, Barron's says »

Harley-Davidson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LIFE

aTyr Pharma

$3.38

-0.05 (-1.46%)

12:29
02/26/17
02/26
12:29
02/26/17
12:29
Hot Stocks
FDA grants Orphan designation for aTyr Pharma muscular dystrophy product »

The FDA has granted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGU

Agrium

$99.37

-1.19 (-1.18%)

, AAL

American Airlines

$46.28

0.18 (0.39%)

04:55
02/26/17
02/26
04:55
02/26/17
04:55
Conference/Events
BMO Capital to hold a conference »

26th Global Metals &…

AGU

Agrium

$99.37

-1.19 (-1.18%)

AAL

American Airlines

$46.28

0.18 (0.39%)

ABX

Barrick Gold

$19.54

-0.12 (-0.61%)

AEM

Agnico Eagle

$45.32

-0.06 (-0.13%)

ANTO

Use ANFGY

BLT

Blount

CCO

Clear Channel Outdoor

$4.65

0.1797 (4.02%)

FCX

Freeport McMoRan

$13.25

-0.23 (-1.71%)

FNV

Franco-Nevada

$65.89

-0.85 (-1.27%)

GEM

Pepsi-Gemex ADR

$29.39

-0.3 (-1.01%)

GG

Goldcorp

$16.57

-0.25 (-1.49%)

HBM

Hudbay Minerals

$8.00

0.25 (3.23%)

IVN

trades under IVPAF

NUE

Nucor

$60.86

-0.03 (-0.05%)

PDL

Project Design Labs

POT

Potash

$17.87

-0.2 (-1.11%)

RIO

Rio Tinto

$41.69

-0.82 (-1.93%)

SLW

Silver Wheaton

$21.15

-0.36 (-1.67%)

STLD

Steel Dynamics

$35.59

0.07 (0.20%)

TECK

Teck Resources

$20.72

-0.09 (-0.43%)

NEM

Newmont Mining

$36.08

0.22 (0.61%)

MOS

Mosaic

$31.42

-0.41 (-1.29%)

AA

Alcoa

$34.48

0.16 (0.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 01

    Mar

  • 05

    Mar

  • 22

    Mar

  • 23

    Mar

  • 02

    May

AGU

Agrium

$99.37

-1.19 (-1.18%)

, AAL

American Airlines

$46.28

0.18 (0.39%)

16:10
02/25/17
02/25
16:10
02/25/17
16:10
Conference/Events
BMO Capital to hold a conference »

26th Global Metals &…

AGU

Agrium

$99.37

-1.19 (-1.18%)

AAL

American Airlines

$46.28

0.18 (0.39%)

ABX

Barrick Gold

$19.54

-0.12 (-0.61%)

AEM

Agnico Eagle

$45.32

-0.06 (-0.13%)

ANTO

Use ANFGY

BLT

Blount

CCO

Clear Channel Outdoor

$4.65

0.1797 (4.02%)

FCX

Freeport McMoRan

$13.25

-0.23 (-1.71%)

FNV

Franco-Nevada

$65.89

-0.85 (-1.27%)

GEM

Pepsi-Gemex ADR

$29.39

-0.3 (-1.01%)

GG

Goldcorp

$16.57

-0.25 (-1.49%)

HBM

Hudbay Minerals

$8.00

0.25 (3.23%)

IVN

trades under IVPAF

NUE

Nucor

$60.86

-0.03 (-0.05%)

PDL

Project Design Labs

POT

Potash

$17.87

-0.2 (-1.11%)

RIO

Rio Tinto

$41.69

-0.82 (-1.93%)

SLW

Silver Wheaton

$21.15

-0.36 (-1.67%)

STLD

Steel Dynamics

$35.59

0.07 (0.20%)

TECK

Teck Resources

$20.72

-0.09 (-0.43%)

NEM

Newmont Mining

$36.08

0.22 (0.61%)

MOS

Mosaic

$31.42

-0.41 (-1.29%)

AA

Alcoa

$34.48

0.16 (0.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 01

    Mar

  • 05

    Mar

  • 22

    Mar

  • 23

    Mar

  • 02

    May

SO

Southern Company

$50.50

0.83 (1.67%)

15:07
02/25/17
02/25
15:07
02/25/17
15:07
Conference/Events
Southern Company participates in a conference call with Wolfe Research »

Wolfe Utilties Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 03

    Mar

DK

Delek US

$23.19

-0.21 (-0.90%)

15:04
02/25/17
02/25
15:04
02/25/17
15:04
Conference/Events
Delek US management participates in a dinner meeting with Wolfe Research »

Wolfe Gas & Oil…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

ANTM

Anthem

$163.83

-0.09 (-0.05%)

15:00
02/25/17
02/25
15:00
02/25/17
15:00
Conference/Events
Anthem management to meet with Wolfe Research »

Wolfe Healthcare Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

MCO

Moody's

$113.29

0.06 (0.05%)

14:56
02/25/17
02/25
14:56
02/25/17
14:56
Conference/Events
Moody's analysts participate in a meeting with Wolfe Research »

Wolfe Utilities Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Mar

  • 05

    Mar

ONCS

OncoSec

$1.39

-0.03 (-2.11%)

, NKTR

Nektar

$13.45

0.25 (1.89%)

04:55
02/25/17
02/25
04:55
02/25/17
04:55
Conference/Events
American Society of Clinical Oncology to hold a symposium »

2017 ASCO-SITC Clinical…

ONCS

OncoSec

$1.39

-0.03 (-2.11%)

NKTR

Nektar

$13.45

0.25 (1.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

MMM

3M

$187.41

0.22 (0.12%)

, BIOL

BIOLASE

$1.49

-0.01 (-0.67%)

04:55
02/25/17
02/25
04:55
02/25/17
04:55
Conference/Events
Chicago Dental Society to hold a meeting »

Chicago Dental Midwinter…

MMM

3M

$187.41

0.22 (0.12%)

BIOL

BIOLASE

$1.49

-0.01 (-0.67%)

COF

Capital One

$92.61

-0.8 (-0.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RNECY

Renesas

$4.14

-0.17 (-3.94%)

, ISIL

Intersil

19:04
02/24/17
02/24
19:04
02/24/17
19:04
Hot Stocks
Renesas sees Intersil acquisition accretive to non-GAAP EPS, free cash flows »

Renesas Electronics…

RNECY

Renesas

$4.14

-0.17 (-3.94%)

ISIL

Intersil

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSIC

Henry Schein

$173.53

1.61 (0.94%)

18:45
02/24/17
02/24
18:45
02/24/17
18:45
Conference/Events
Henry Schein management to meet with Jefferies »

Group dinner to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

TWX

Time Warner

$97.28

0.6225 (0.64%)

18:38
02/24/17
02/24
18:38
02/24/17
18:38
Periodicals
Turner, Univision to win U.S. Champions League rights, Bloomberg reports »

Turner, a subsidiary of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

TRUE

TrueCar

$14.28

0.18 (1.28%)

18:33
02/24/17
02/24
18:33
02/24/17
18:33
Hot Stocks
TrueCar's ALG sees February total new vehicle sales 1.325M units, down 1.4% »

ALG projects total new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

GE

General Electric

$30.19

0.17 (0.57%)

18:24
02/24/17
02/24
18:24
02/24/17
18:24
Hot Stocks
GE does not see after-tax charges from GE Capital exit plan to exceed $23B »

GE said in a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

CE

Celanese

$88.79

-0.88 (-0.98%)

18:02
02/24/17
02/24
18:02
02/24/17
18:02
Hot Stocks
Celanese announces vinyl acetate-based emulsions price increases in Asia »

Celanese announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

ELNK

EarthLink

$5.63

-0.22 (-3.76%)

, WIN

Windstream

$7.27

-0.02 (-0.27%)

17:56
02/24/17
02/24
17:56
02/24/17
17:56
Hot Stocks
EarthLink, Windstream holders approve merger »

EarthLink (ELNK)…

ELNK

EarthLink

$5.63

-0.22 (-3.76%)

WIN

Windstream

$7.27

-0.02 (-0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 24

    Feb

  • 01

    Mar

  • 06

    Mar

PFE

Pfizer

$34.26

0.2 (0.59%)

17:43
02/24/17
02/24
17:43
02/24/17
17:43
Periodicals
Pfizer subpoenaed in investigation of charity connections, Bloomberg says »

Pfizer has received two…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Mar

  • 09

    Mar

  • 17

    Mar

  • 23

    Mar

  • 01

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.